Highlights
NASDAQ: NERV       Minerva Neuroscie
Last Price Today's Change   Day's Range   Trading Volume
0.40   +0.01 (2.56%)  0.39 - 0.41  50,192

Overview

 
Avg Volume (4 weeks):101,754
4 Weeks Range:0.331 - 0.735
4 Weeks Price Volatility (%):
17.08%
52 Weeks Range:0.331 - 3.54
52 Weeks Price Volatility (%):
2.15%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. The company primarily focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. This portfolio includes four compounds, schizophrenia, insomnia, major depressive disorder and Parkinson's disease. Its product portfolio and potential indications include MIN-101 for the treatment of schizophrenia; MIN-202, for the treatment of insomnia disorder and major depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

4439  2834  829  4193 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 IMPP 0.48-0.285 
 TQQQ 32.69+2.04 
 ISBC 13.87-0.35 
 SNDL 0.44-0.025 
 SQQQ 50.34-3.71 
 MKD 0.15+0.034 
 AMD 101.641+7.401 
 NLY 6.445-0.245 
 AUVI 1.30+0.26 
 NIO 16.224+1.674